A systemic approach to healthcare

Bios-TherapyA systemic approach to healthcare

A systemic approach to healthcare

At Bios-Therapy, we address health needs with a systemic perspective, moving beyond the traditional molecule–receptor model. Our researchers employ the most advanced omic technologies to develop safe, effective and sustainable products for healthcare and therapeutic innovation. We operate with paramount respect for people and the environment, according to the international principles of One Health.

Advanced research on natural molecular complexes

Bios-Therapy has developed a high level of expertise in the identification, evaluation and profiling of natural matrices. Drawing on our unique expertise and proprietary methodologies, we can evaluate the efficacy and safety profiles of natural products.

 

Bios Therapy research

A unique platform for natural products

Bios-Therapy has developed high-throughput platforms based on multiomics technologies for the rapid, large-scale analysis of multiple biomarkers — including DNA, RNA, proteins, and metabolites. When applied to appropriate cellular models and integrated with advanced bioinformatics these technologies enable us to:
• Study the interactions between natural matrices and the human organism, taking into account the complexity of both.
• Investigate non-pharmacological activities and their mechanisms of action.
• Ensure that products are safe, effective, and in full compliance with the most rigorous regulatory standards.

Our innovative approach represents a benchmark in research on natural complexes and matrices and their applications for healthcare.

Bios Therapy research

Excellence in scientific collaborations

Our research is strengthened by partnerships with universities and international institutions, ensuring ongoing innovation in technologies and approaches. Our studies are published in leading scientific journals, and a significant number of our solutions are protected by international patents.

Bios Therapy research

Innovation for the future

We lead the development of new solutions to reduce animal testing through the advanced use of cell banks and cell lines. We work closely with national and European regulators to integrate systemic principles into product authorization processes, supporting a more sustainable and scientifically advanced future.